Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Azacitidine met of zonder Lenalidomide of Vorinostat bij de behandeling van patiënten met een hoger risico op myelodysplastische syndromen of chronische myelomonocytische leukemie

17 november 2026 bijgewerkt door: National Cancer Institute (NCI)

Een gerandomiseerde fase II/III-studie van azacitidine in combinatie met lenalidomide (NSC-703813) versus azacitidine alleen versus azacitidine in combinatie met Vorinostat (NSC-701852) voor risicovollere myelodysplastische syndromen (MDS) en chronische myelomonocytische leukemie (CMML)

This randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, stopping them from dividing, or by stopping them from spreading. Lenalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether azacitidine is more effective with or without lenalidomide or vorinostat in treating myelodysplastic syndromes or chronic myelomonocytic leukemia.

Studie Overzicht

Gedetailleerde beschrijving

PRIMARY OBJECTIVES:

I. To select based on response rate (complete remission, partial remission, or hematologic improvement) either the combination of lenalidomide and azacitidine or the combination of vorinostat and azacitidine for further testing against single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase II) II. To compare overall survival between the combination arm selected in the Phase II portion of the trial to single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase III)

SECONDARY OBJECTIVES:

I. To estimate relapse-free survival, overall survival and cytogenetic response rate of patients treated on each regimen.

II. To estimate the frequency and severity of toxicities of the three regimens in this patient population.

III. To investigate in a preliminary manner the frequency of subgroups from prestudy cytogenetic studies and correlate these subgroups with clinical outcomes in this patient population.

IV. To collect specimens for banking for use in future research studies.

TERTIARY OBJECTIVES:

I. To evaluate the prevalence of a pre-specified list of molecular lesions (48 total lesions).

II. To assess associations of these lesions with outcomes (response, event-free survival, relapse-free survival, and overall survival).

III. To develop a deoxyribonucleic acid (DNA) methylation biomarker predictive of response to DMTi treatment in MDS.

IV. To harness gene expression profiles as clinical biomarkers of primary resistance to DMTi in MDS.

OUTLINE: Patients are randomized to 1 of 3 treatment arms. In Phase III, patients are randomized to 1 of 2 treatment arms (the combination arm selected in Phase II or the single-agent azacitidine arm).

ARM I: Patients receive azacitidine subcutaneously (SC) or intravenously (IV) on days 1-7 or days 1-5 and 8-9, and lenalidomide orally (PO) once daily (QD) on days 1-21.

ARM II: Patients receive azacitidine as in Arm I.

ARM III: Patients receive azacitidine as in Arm I and vorinostat PO twice daily (BID) on days 3-9.

In all arms, treatment repeats every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 3 months for up to 5 years.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

282

Fase

  • Fase 2

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Alberta
      • Calgary, Alberta, Canada, T2N 5G2
        • Arthur J E Child Comprehensive Cancer Centre
    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 3P1
        • Clinical Research Unit at Vancouver Coastal Health Authority
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3E 0V9
        • CancerCare Manitoba
    • New Brunswick
      • Moncton, New Brunswick, Canada, E1C 6Z8
        • The Moncton Hospital
      • Saint John, New Brunswick, Canada, E2L 4L2
        • Atlantic Health Sciences Corporation-Saint John Regional Hospital
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 2Y9
        • QEII Health Sciences Centre/Nova Scotia Health Authority
    • Ontario
      • Hamilton, Ontario, Canada, L8V 5C2
        • Juravinski Cancer Centre at Hamilton Health Sciences
      • Toronto, Ontario, Canada, M5G 2M9
        • University Health Network-Princess Margaret Hospital
      • Toronto, Ontario, Canada, M4N 3M5
        • Odette Cancer Centre- Sunnybrook Health Sciences Centre
    • Quebec
      • Greenfield Park, Quebec, Canada, J4V 2H1
        • CSSS Champlain-Charles Le Moyne
      • Montreal, Quebec, Canada, H3H 2R9
        • The Research Institute of the McGill University Health Centre (MUHC)
      • Montreal, Quebec, Canada, H2W 1S6
        • McGill University Department of Oncology
    • Saskatchewan
      • Regina, Saskatchewan, Canada, S4T 7T1
        • Allan Blair Cancer Centre
      • Saskatoon, Saskatchewan, Canada, S7N 4H4
        • Saskatoon Cancer Centre
    • Alabama
      • Birmingham, Alabama, Verenigde Staten, 35233
        • University of Alabama at Birmingham Cancer Center
      • Mobile, Alabama, Verenigde Staten, 36688
        • University of South Alabama Mitchell Cancer Institute
    • Arizona
      • Scottsdale, Arizona, Verenigde Staten, 85259
        • Mayo Clinic in Arizona
      • Tucson, Arizona, Verenigde Staten, 85719
        • Banner University Medical Center - Tucson
      • Tucson, Arizona, Verenigde Staten, 85719
        • University of Arizona Cancer Center-North Campus
    • Arkansas
      • Little Rock, Arkansas, Verenigde Staten, 72205
        • John L McClellan Memorial Veterans Hospital
    • California
      • Antioch, California, Verenigde Staten, 94531
        • Kaiser Permanente-Deer Valley Medical Center
      • Duarte, California, Verenigde Staten, 91010
        • City of Hope Comprehensive Cancer Center
      • Los Angeles, California, Verenigde Staten, 90033
        • USC / Norris Comprehensive Cancer Center
      • Oakland, California, Verenigde Staten, 94611
        • Kaiser Permanente-Oakland
      • Palo Alto, California, Verenigde Staten, 94304
        • Stanford Cancer Institute Palo Alto
      • Richmond, California, Verenigde Staten, 94801
        • Kaiser Permanente-Richmond
      • Sacramento, California, Verenigde Staten, 95823
        • Kaiser Permanente-South Sacramento
      • Sacramento, California, Verenigde Staten, 95825
        • Kaiser Permanente Sacramento Medical Center
      • San Francisco, California, Verenigde Staten, 94115
        • Kaiser Permanente-San Francisco
      • San Jose, California, Verenigde Staten, 95119
        • Kaiser Permanente-Santa Teresa-San Jose
      • San Rafael, California, Verenigde Staten, 94903
        • Kaiser Permanente-San Rafael
      • Santa Clara, California, Verenigde Staten, 95051
        • Kaiser Permanente Medical Center - Santa Clara
      • Santa Rosa, California, Verenigde Staten, 95403
        • Kaiser Permanente-Santa Rosa
      • Santa Rosa, California, Verenigde Staten, 95403
        • Sutter Pacific Medical Foundation
      • South San Francisco, California, Verenigde Staten, 94080
        • Kaiser Permanente-South San Francisco
      • Vallejo, California, Verenigde Staten, 94589
        • Kaiser Permanente-Vallejo
      • Walnut Creek, California, Verenigde Staten, 94596
        • Kaiser Permanente-Walnut Creek
    • Colorado
      • Aurora, Colorado, Verenigde Staten, 80012
        • The Medical Center of Aurora
      • Aurora, Colorado, Verenigde Staten, 80045
        • UCHealth University of Colorado Hospital
      • Boulder, Colorado, Verenigde Staten, 80303
        • Boulder Community Foothills Hospital
      • Colorado Springs, Colorado, Verenigde Staten, 80907
        • Penrose-Saint Francis Healthcare
      • Denver, Colorado, Verenigde Staten, 80218
        • Presbyterian - Saint Lukes Medical Center - Health One
      • Denver, Colorado, Verenigde Staten, 80220
        • Rose Medical Center
      • Denver, Colorado, Verenigde Staten, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, Verenigde Staten, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, Verenigde Staten, 80218
        • Colorado Blood Cancer Institute
      • Denver, Colorado, Verenigde Staten, 80222
        • Western States Cancer Research NCORP
      • Denver, Colorado, Verenigde Staten, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, Verenigde Staten, 80210
        • AdventHealth Porter
      • Durango, Colorado, Verenigde Staten, 81301
        • Mercy Medical Center
      • Englewood, Colorado, Verenigde Staten, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, Verenigde Staten, 80113
        • Swedish Medical Center
      • Fort Collins, Colorado, Verenigde Staten, 80524
        • Poudre Valley Hospital
      • Golden, Colorado, Verenigde Staten, 80401
        • Mountain Blue Cancer Care Center
      • Greeley, Colorado, Verenigde Staten, 80631
        • Banner North Colorado Medical Center
      • Greenwood Village, Colorado, Verenigde Staten, 80111
        • Rocky Mountain Cancer Centers-Greenwood Village
      • Lakewood, Colorado, Verenigde Staten, 80228
        • Rocky Mountain Cancer Centers-Lakewood
      • Lakewood, Colorado, Verenigde Staten, 80228
        • CommonSpirit Saint Anthony Hospital Cancer Center
      • Littleton, Colorado, Verenigde Staten, 80122
        • AdventHealth Littleton
      • Lone Tree, Colorado, Verenigde Staten, 80124
        • Sky Ridge Medical Center
      • Lone Tree, Colorado, Verenigde Staten, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Longmont, Colorado, Verenigde Staten, 80501
        • Longmont United Hospital
      • Loveland, Colorado, Verenigde Staten, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Parker, Colorado, Verenigde Staten, 80138
        • Rocky Mountain Cancer Centers-Parker
      • Parker, Colorado, Verenigde Staten, 80138
        • AdventHealth Parker
      • Pueblo, Colorado, Verenigde Staten, 81004
        • Saint Mary Corwin Medical Center
      • Wheat Ridge, Colorado, Verenigde Staten, 80401
        • Intermountain Health Lutheran Hospital
    • Connecticut
      • Farmington, Connecticut, Verenigde Staten, 06030
        • University of Connecticut
      • Hartford, Connecticut, Verenigde Staten, 06105
        • Smilow Cancer Hospital Care Center at Saint Francis
      • New Britain, Connecticut, Verenigde Staten, 06050
        • The Hospital of Central Connecticut
    • Delaware
      • Lewes, Delaware, Verenigde Staten, 19958
        • Beebe Medical Center
      • Newark, Delaware, Verenigde Staten, 19718
        • Christiana Care Health System-Christiana Hospital
    • District of Columbia
      • Washington D.C., District of Columbia, Verenigde Staten, 20016
        • Sibley Memorial Hospital
      • Washington D.C., District of Columbia, Verenigde Staten, 20422
        • Veterans Affairs Medical Center -Washington DC
    • Florida
      • Gainesville, Florida, Verenigde Staten, 32610
        • UF Health Cancer Institute - Gainesville
      • Jupiter, Florida, Verenigde Staten, 33458
        • Jupiter Medical Center
      • Miami Beach, Florida, Verenigde Staten, 33140
        • Mount Sinai Medical Center
      • Orlando, Florida, Verenigde Staten, 32803
        • AdventHealth Orlando
    • Georgia
      • Augusta, Georgia, Verenigde Staten, 30912
        • Augusta University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Verenigde Staten, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • Honolulu, Hawaii, Verenigde Staten, 96813
        • Straub Clinic and Hospital
      • Honolulu, Hawaii, Verenigde Staten, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, Verenigde Staten, 96817
        • Queen's Cancer Center - Kuakini
      • Honolulu, Hawaii, Verenigde Staten, 96819
        • Kaiser Permanente Moanalua Medical Center
    • Idaho
      • Boise, Idaho, Verenigde Staten, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Post Falls, Idaho, Verenigde Staten, 83854
        • Kootenai Clinic Cancer Services - Post Falls
    • Illinois
      • Bloomington, Illinois, Verenigde Staten, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Verenigde Staten, 61520
        • Illinois CancerCare-Canton
      • Carthage, Illinois, Verenigde Staten, 62321
        • Illinois CancerCare-Carthage
      • Chicago, Illinois, Verenigde Staten, 60611
        • Northwestern University
      • Chicago, Illinois, Verenigde Staten, 60637
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Verenigde Staten, 60612
        • University of Illinois
      • Chicago, Illinois, Verenigde Staten, 60611
        • Hematology and Oncology Associates
      • Decatur, Illinois, Verenigde Staten, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, Verenigde Staten, 62526
        • Heartland Cancer Research NCORP
      • Eureka, Illinois, Verenigde Staten, 61530
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, Verenigde Staten, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, Verenigde Staten, 61401
        • Illinois CancerCare-Galesburg
      • Havana, Illinois, Verenigde Staten, 62644
        • Illinois CancerCare-Havana
      • Kewanee, Illinois, Verenigde Staten, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, Verenigde Staten, 61455
        • Illinois CancerCare-Macomb
      • Maywood, Illinois, Verenigde Staten, 60153
        • Loyola University Medical Center
      • Moline, Illinois, Verenigde Staten, 61265
        • Trinity Medical Center
      • Monmouth, Illinois, Verenigde Staten, 61462
        • Illinois CancerCare-Monmouth
      • Normal, Illinois, Verenigde Staten, 61761
        • Illinois CancerCare-Community Cancer Center
      • Ottawa, Illinois, Verenigde Staten, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Pekin, Illinois, Verenigde Staten, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Verenigde Staten, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Verenigde Staten, 61354
        • Illinois CancerCare-Peru
      • Princeton, Illinois, Verenigde Staten, 61356
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, Verenigde Staten, 61104
        • Swedish American Hospital
      • Rockford, Illinois, Verenigde Staten, 61114
        • UW Health Carbone Cancer Center Rockford
      • Springfield, Illinois, Verenigde Staten, 62781
        • Springfield Memorial Hospital
      • Urbana, Illinois, Verenigde Staten, 61801
        • Carle Cancer Center
    • Indiana
      • Merrillville, Indiana, Verenigde Staten, 46410
        • Premier Oncology Hematology Associates
    • Iowa
      • Ames, Iowa, Verenigde Staten, 50010
        • McFarland Clinic - Ames
      • Iowa City, Iowa, Verenigde Staten, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Sioux City, Iowa, Verenigde Staten, 51101
        • Siouxland Regional Cancer Center
      • Waterloo, Iowa, Verenigde Staten, 50702
        • MercyOne Waterloo Cancer Center
    • Kansas
      • Kansas City, Kansas, Verenigde Staten, 66160
        • University of Kansas Cancer Center
      • Prairie Village, Kansas, Verenigde Staten, 66208
        • Kansas City NCI Community Oncology Research Program
      • Topeka, Kansas, Verenigde Staten, 66606
        • Cotton O'Neil Cancer Center / Stormont Vail Health
    • Kentucky
      • Lexington, Kentucky, Verenigde Staten, 40536
        • University of Kentucky/Markey Cancer Center
    • Louisiana
      • Baton Rouge, Louisiana, Verenigde Staten, 70809
        • Ochsner Health Center-Summa
      • New Orleans, Louisiana, Verenigde Staten, 70121
        • Ochsner Medical Center Jefferson
      • Shreveport, Louisiana, Verenigde Staten, 71103
        • LSU Health Sciences Center at Shreveport
    • Maine
      • Bangor, Maine, Verenigde Staten, 04401
        • Eastern Maine Medical Center
    • Maryland
      • Baltimore, Maryland, Verenigde Staten, 21287
        • Johns Hopkins University/Sidney Kimmel Cancer Center
      • Elkton, Maryland, Verenigde Staten, 21921
        • Christiana Care - Union Hospital
    • Massachusetts
      • Boston, Massachusetts, Verenigde Staten, 02215
        • Dana-Farber Cancer Institute
      • Boston, Massachusetts, Verenigde Staten, 02114
        • Massachusetts General Hospital Cancer Center
      • Brighton, Massachusetts, Verenigde Staten, 02135
        • Dana-Farber Cancer Institute at Boston Medical Center - Brighton
      • Springfield, Massachusetts, Verenigde Staten, 01199
        • Baystate Medical Center
      • Worcester, Massachusetts, Verenigde Staten, 01655
        • UMass Memorial Medical Center - University Campus
    • Michigan
      • Ann Arbor, Michigan, Verenigde Staten, 48106
        • Michigan Cancer Research Consortium NCORP
      • Ann Arbor, Michigan, Verenigde Staten, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Battle Creek, Michigan, Verenigde Staten, 49017
        • Bronson Battle Creek
      • Detroit, Michigan, Verenigde Staten, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Detroit, Michigan, Verenigde Staten, 48236
        • Henry Ford Health Saint John Hospital
      • Escanaba, Michigan, Verenigde Staten, 49829
        • OSF Saint Francis Hospital and Medical Group
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • Cancer Research Consortium of West Michigan NCORP
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • Trinity Health Grand Rapids Hospital
      • Grand Rapids, Michigan, Verenigde Staten, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Kalamazoo, Michigan, Verenigde Staten, 49007
        • West Michigan Cancer Center
      • Muskegon, Michigan, Verenigde Staten, 49444
        • Trinity Health Muskegon Hospital
      • Port Huron, Michigan, Verenigde Staten, 48060
        • Lake Huron Medical Center
      • Reed City, Michigan, Verenigde Staten, 49677
        • Corewell Health Reed City Hospital
      • Traverse City, Michigan, Verenigde Staten, 49684
        • Munson Medical Center
      • Warren, Michigan, Verenigde Staten, 48093
        • Henry Ford Health Warren Hospital
    • Minnesota
      • Bemidji, Minnesota, Verenigde Staten, 56601
        • Sanford Joe Lueken Cancer Center
      • Burnsville, Minnesota, Verenigde Staten, 55337
        • Fairview Ridges Hospital
      • Coon Rapids, Minnesota, Verenigde Staten, 55433
        • Mercy Hospital
      • Duluth, Minnesota, Verenigde Staten, 55805
        • Essentia Health Cancer Center
      • Edina, Minnesota, Verenigde Staten, 55435
        • Fairview Southdale Hospital
      • Fridley, Minnesota, Verenigde Staten, 55432
        • Unity Hospital
      • Hutchinson, Minnesota, Verenigde Staten, 55350
        • Hutchinson Area Health Care
      • Maplewood, Minnesota, Verenigde Staten, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, Verenigde Staten, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, Verenigde Staten, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, Verenigde Staten, 55407
        • Abbott-Northwestern Hospital
      • Minneapolis, Minnesota, Verenigde Staten, 55417
        • Minneapolis VA Medical Center
      • Robbinsdale, Minnesota, Verenigde Staten, 55422
        • North Memorial Medical Health Center
      • Rochester, Minnesota, Verenigde Staten, 55905
        • Mayo Clinic in Rochester
      • Saint Cloud, Minnesota, Verenigde Staten, 56303
        • Coborn Cancer Center at Saint Cloud Hospital
      • Saint Louis Park, Minnesota, Verenigde Staten, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Louis Park, Minnesota, Verenigde Staten, 55416
        • Metro Minnesota Community Oncology Research Consortium
      • Saint Paul, Minnesota, Verenigde Staten, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, Verenigde Staten, 55102
        • United Hospital
      • Shakopee, Minnesota, Verenigde Staten, 55379
        • Saint Francis Regional Medical Center
      • Stillwater, Minnesota, Verenigde Staten, 55082
        • Lakeview Hospital
      • Waconia, Minnesota, Verenigde Staten, 55387
        • Ridgeview Medical Center
      • Willmar, Minnesota, Verenigde Staten, 56201
        • Rice Memorial Hospital
      • Woodbury, Minnesota, Verenigde Staten, 55125
        • Minnesota Oncology Hematology PA-Woodbury
    • Mississippi
      • Jackson, Mississippi, Verenigde Staten, 39216
        • University of Mississippi Medical Center
    • Missouri
      • Cape Girardeau, Missouri, Verenigde Staten, 63703
        • Saint Francis Medical Center
      • Columbia, Missouri, Verenigde Staten, 65201
        • Veterans Administration
      • Columbia, Missouri, Verenigde Staten, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Kansas City, Missouri, Verenigde Staten, 64111
        • Saint Luke's Hospital of Kansas City
      • St Louis, Missouri, Verenigde Staten, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, Verenigde Staten, 63141
        • Saint Louis-Cape Girardeau CCOP
    • Montana
      • Billings, Montana, Verenigde Staten, 59101
        • Billings Clinic Cancer Center
      • Bozeman, Montana, Verenigde Staten, 59715
        • Bozeman Health Deaconess Hospital
    • New Jersey
      • Camden, New Jersey, Verenigde Staten, 08103
        • Cooper Hospital University Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Verenigde Staten, 87106
        • University of New Mexico Cancer Center
      • Albuquerque, New Mexico, Verenigde Staten, 87110
        • Presbyterian Kaseman Hospital
    • New York
      • Buffalo, New York, Verenigde Staten, 14263
        • Roswell Park Cancer Institute
      • Lake Success, New York, Verenigde Staten, 11042
        • Northwell Health/Center for Advanced Medicine
      • Manhasset, New York, Verenigde Staten, 11030
        • North Shore University Hospital
      • Mineola, New York, Verenigde Staten, 11501
        • NYU Langone Hospital - Long Island
      • New York, New York, Verenigde Staten, 10065
        • NYP/Weill Cornell Medical Center
      • Rochester, New York, Verenigde Staten, 14642
        • University of Rochester
      • The Bronx, New York, Verenigde Staten, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, Verenigde Staten, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Asheboro, North Carolina, Verenigde Staten, 27203
        • Randolph Hospital
      • Goldsboro, North Carolina, Verenigde Staten, 27534
        • Wayne Memorial Hospital
      • Greensboro, North Carolina, Verenigde Staten, 27403
        • Cone Health Cancer Center
      • Hendersonville, North Carolina, Verenigde Staten, 28791
        • Margaret R Pardee Memorial Hospital
      • Kinston, North Carolina, Verenigde Staten, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, Verenigde Staten, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Reidsville, North Carolina, Verenigde Staten, 27320
        • Annie Penn Memorial Hospital
      • Statesville, North Carolina, Verenigde Staten, 28677
        • Iredell Memorial Hospital
      • Winston-Salem, North Carolina, Verenigde Staten, 27104
        • Southeast Clinical Oncology Research Consortium NCORP
    • North Dakota
      • Bismarck, North Dakota, Verenigde Staten, 58501
        • Sanford Bismarck Medical Center
      • Bismarck, North Dakota, Verenigde Staten, 58501
        • Mid Dakota Clinic
      • Fargo, North Dakota, Verenigde Staten, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Verenigde Staten, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Beachwood, Ohio, Verenigde Staten, 44122
        • Cleveland Clinic Cancer Center Beachwood
      • Cincinnati, Ohio, Verenigde Staten, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, Verenigde Staten, 44106
        • Case Western Reserve University
      • Cleveland, Ohio, Verenigde Staten, 44195
        • Cleveland Clinic Foundation
      • Cleveland, Ohio, Verenigde Staten, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Verenigde Staten, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Verenigde Staten, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, Verenigde Staten, 43222
        • Mount Carmel Health Center West
      • Columbus, Ohio, Verenigde Staten, 43215
        • Columbus NCI Community Oncology Research Program
      • Dayton, Ohio, Verenigde Staten, 45409
        • Miami Valley Hospital
      • Independence, Ohio, Verenigde Staten, 44131
        • Cleveland Clinic Cancer Center Independence
      • Marietta, Ohio, Verenigde Staten, 45750
        • Marietta Memorial Hospital
      • Mayfield Heights, Ohio, Verenigde Staten, 44124
        • Hillcrest Hospital Cancer Center
      • Newark, Ohio, Verenigde Staten, 43055
        • Licking Memorial Hospital
      • Parma, Ohio, Verenigde Staten, 44129
        • University Hospitals Parma Medical Center
      • Sandusky, Ohio, Verenigde Staten, 44870
        • North Coast Cancer Care
      • Springfield, Ohio, Verenigde Staten, 45504
        • Springfield Regional Medical Center
      • Strongsville, Ohio, Verenigde Staten, 44136
        • Cleveland Clinic Cancer Center Strongsville
      • Sylvania, Ohio, Verenigde Staten, 43560
        • ProMedica Flower Hospital
      • Toledo, Ohio, Verenigde Staten, 43614
        • University of Toledo
      • Westerville, Ohio, Verenigde Staten, 43081
        • Saint Ann's Hospital
      • Wooster, Ohio, Verenigde Staten, 44691
        • Cleveland Clinic Wooster Family Health and Surgery Center
    • Oklahoma
      • Norman, Oklahoma, Verenigde Staten, 73071
        • Cancer Care Associates-Norman
      • Oklahoma City, Oklahoma, Verenigde Staten, 73104
        • University of Oklahoma Health Sciences Center
      • Oklahoma City, Oklahoma, Verenigde Staten, 73120
        • Mercy Hospital Oklahoma City
    • Oregon
      • Gresham, Oregon, Verenigde Staten, 97030
        • Legacy Mount Hood Medical Center
      • Milwaukie, Oregon, Verenigde Staten, 97222
        • Providence Milwaukie Hospital
      • Newberg, Oregon, Verenigde Staten, 97132
        • Providence Newberg Medical Center
      • Oregon City, Oregon, Verenigde Staten, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Verenigde Staten, 97210
        • Legacy Good Samaritan Hospital and Medical Center
      • Portland, Oregon, Verenigde Staten, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Verenigde Staten, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, Verenigde Staten, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Carlisle, Pennsylvania, Verenigde Staten, 17015
        • Carlisle Regional Cancer Center
      • Danville, Pennsylvania, Verenigde Staten, 17822
        • Geisinger Medical Center
      • Doylestown, Pennsylvania, Verenigde Staten, 18901
        • Doylestown Hospital
      • Hazleton, Pennsylvania, Verenigde Staten, 18201
        • Geisinger Medical Center-Cancer Center Hazleton
      • Hershey, Pennsylvania, Verenigde Staten, 17033-0850
        • Penn State Milton S Hershey Medical Center
      • Pittsburgh, Pennsylvania, Verenigde Staten, 15232
        • UPMC Hillman Cancer Center
      • Sayre, Pennsylvania, Verenigde Staten, 18840
        • Guthrie Medical Group PC-Robert Packer Hospital
      • West Reading, Pennsylvania, Verenigde Staten, 19611
        • Reading Hospital
      • Wilkes-Barre, Pennsylvania, Verenigde Staten, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
    • South Carolina
      • Boiling Springs, South Carolina, Verenigde Staten, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Charleston, South Carolina, Verenigde Staten, 29401
        • Roper Hospital
      • Greenville, South Carolina, Verenigde Staten, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Verenigde Staten, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Verenigde Staten, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greenville, South Carolina, Verenigde Staten, 29601
        • Saint Francis Hospital
      • Greenville, South Carolina, Verenigde Staten, 29605
        • Prisma Health Greenville Memorial Hospital
      • Seneca, South Carolina, Verenigde Staten, 29672
        • Prisma Health Cancer Institute - Seneca
      • Spartanburg, South Carolina, Verenigde Staten, 29303
        • Spartanburg Medical Center
    • South Dakota
      • Rapid City, South Dakota, Verenigde Staten, 57701
        • Rapid City Regional Hospital
      • Sioux Falls, South Dakota, Verenigde Staten, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, Verenigde Staten, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Knoxville, Tennessee, Verenigde Staten, 37916
        • Covenant Health Cancer Centers
      • Nashville, Tennessee, Verenigde Staten, 37232
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Amarillo, Texas, Verenigde Staten, 79106
        • The Don and Sybil Harrington Cancer Center
      • Dallas, Texas, Verenigde Staten, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
    • Utah
      • Salt Lake City, Utah, Verenigde Staten, 84112
        • Huntsman Cancer Institute/University of Utah
    • Virginia
      • Martinsville, Virginia, Verenigde Staten, 24112
        • Sovah Health Martinsville
    • Washington
      • Vancouver, Washington, Verenigde Staten, 98664
        • PeaceHealth Southwest Medical Center
    • West Virginia
      • Morgantown, West Virginia, Verenigde Staten, 26506
        • West Virginia University Healthcare
    • Wisconsin
      • Chippewa Falls, Wisconsin, Verenigde Staten, 54729
        • Marshfield Clinic-Chippewa Center
      • Eau Claire, Wisconsin, Verenigde Staten, 54701
        • HSHS Sacred Heart Hospital
      • Eau Claire, Wisconsin, Verenigde Staten, 54701
        • Marshfield Clinic Cancer Center at Sacred Heart
      • Green Bay, Wisconsin, Verenigde Staten, 54311
        • Aurora BayCare Medical Center
      • Green Bay, Wisconsin, Verenigde Staten, 54301
        • Saint Vincent Hospital Cancer Center Green Bay
      • Green Bay, Wisconsin, Verenigde Staten, 54303
        • Saint Vincent Hospital Cancer Center at Saint Mary's
      • Green Bay, Wisconsin, Verenigde Staten, 54301-3526
        • Green Bay Oncology at Saint Vincent Hospital
      • Janesville, Wisconsin, Verenigde Staten, 53548
        • Mercyhealth Hospital and Cancer Center - Janesville
      • La Crosse, Wisconsin, Verenigde Staten, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, Verenigde Staten, 53715
        • SSM Health Dean Medical Group - South Madison Campus
      • Marinette, Wisconsin, Verenigde Staten, 54143
        • Aurora Bay Area Medical Group-Marinette
      • Marinette, Wisconsin, Verenigde Staten, 54143
        • Bay Area Medical Center
      • Marshfield, Wisconsin, Verenigde Staten, 54449
        • Marshfield Medical Center-Marshfield
      • Marshfield, Wisconsin, Verenigde Staten, 54449
        • Marshfield Medical Center
      • Milwaukee, Wisconsin, Verenigde Staten, 53226
        • Medical College of Wisconsin
      • Minocqua, Wisconsin, Verenigde Staten, 54548
        • Marshfield Medical Center - Minocqua
      • Oconomowoc, Wisconsin, Verenigde Staten, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oconto Falls, Wisconsin, Verenigde Staten, 54154
        • Saint Vincent Hospital Cancer Center at Oconto Falls
      • Rhinelander, Wisconsin, Verenigde Staten, 54501
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
      • Rice Lake, Wisconsin, Verenigde Staten, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, Verenigde Staten, 54481
        • Aspirus Cancer Care - Stevens Point
      • Summit, Wisconsin, Verenigde Staten, 53066
        • Aurora Medical Center in Summit
      • Waukesha, Wisconsin, Verenigde Staten, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wauwatosa, Wisconsin, Verenigde Staten, 53226
        • Aurora Cancer Care-Milwaukee West
      • Weston, Wisconsin, Verenigde Staten, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, Verenigde Staten, 54494
        • Marshfield Clinic - Wisconsin Rapids Center

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Patients must have morphologically confirmed diagnosis of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) based on one of the following:

    • French-American-British (FAB) classifications:

      • Refractory anemia with excess blasts (RAEB - defined as having 5-20% myeloblasts in the bone marrow)
      • Chronic myelomonocytic leukemia (CMML) with 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood
    • World Health Organization (WHO) classifications:

      • Refractory anemia with excess blasts-1 (RAEB-1 - defined as having 5-9% myeloblasts in the bone marrow)
      • Refractory anemia with excess blasts-2 (RAEB-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood)
      • Chronic myelomonocytic leukemia-1 (CMML-1 - defined as having < 10% myeloblasts in the bone marrow and/or < 5% blasts in the blood)
      • Chronic myelomonocytic leukemia-2 (CMML-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood) OR
    • International prognostic score (IPSS) of intermediate 2 (1.5-2.0 points) or high (>= 2.5 points); a score of intermediate 1 (0.5-1.0 points) is only allowable in the setting of >= 5% myeloblasts

    • NOTE: Patients with acute myeloid leukemia (AML) are not eligible

    • Procedures to obtain specimens for establishing baseline disease must be done within 30 days prior to registration

  • Patients must not have received lenalidomide, azacitidine, vorinostat, or decitabine as treatment previously; any hematopoietic growth factors must be stopped for at least 14 days prior to registration; patients may have received low-dose cytarabine for MDS treatment previously, but they must have discontinued its use for at least 28 days prior to registration; patients may have received prior hydroxyurea per CMML treatment previously, but they must have discontinued its use for at least 7 days prior to registration; these patients will not be eligible if white blood cell (WBC) > 30,000/mm^3

  • Patients must not have received radiation therapy, chemotherapy, or cytotoxic therapy to treat conditions other than MDS within 12 months prior to registration

  • Patients must not have undergone prior allogeneic stem cell or bone marrow transplantation at any time; patients that have undergone an autologous stem cell transplant are eligible

  • Patients must not have used or be using histone deacetylase (HDAC) inhibitor agents for anticancer treatment

  • Patients may not have received agents such as valproic acid for epilepsy within 30 days prior to registration

  • Patients must have Zubrod performance status of 0-2

  • Patients must not have any pre-existing neurotoxicity/neuropathy of >= grade 2 according to the National Cancer Institute (NCI) Common Toxicity Criteria version 4.0, or prior >= grade 3 allergic reaction/hypersensitivity or rash to thalidomide, that has not resolved to < grade 2

  • Patients must not have any serious medical condition, laboratory abnormality, or psychiatric illness that, in the view of the treating physician, would place the participant at an unacceptable risk if he or she were to participate in the study or would prevent that person from giving informed consent

  • Patients must not have history of thromboembolic event or other condition requiring current use of anticoagulation with Coumadin (warfarin) or low molecular-weight heparin

  • Patients must not have known or suspected hypersensitivity to mannitol

  • Patients must receive a 12-lead electrocardiogram (EKG), chest x-ray or computed tomography (CT) scan, serum creatinine, complete metabolic panel including serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT), electrolytes, and bilirubin testing within 28 days prior to registration in order to establish baseline measurements; questions regarding patient safety in regards to results of these tests should be directed to the study chair

  • Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10 - 14 days prior to registration; FCBP must agree to have a second pregnancy test within 24 hours prior to starting cycle 1 if randomized to receive lenalidomide

    • Further, patients commit to the following if they are randomized to receive lenalidomide: FCBP must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy; a FCBP is a sexually mature woman who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); all patients must be counseled by a trained counselor every 28 days about pregnancy precautions and risks of fetal exposure
    • NOTE: Patients not randomized to receive lenalidomide will not be required to undergo serial pregnancy testing or lenalidomide counseling after registration
  • No prior malignancy is allowed except for adequately treated basal cell (or squamous cell) skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for three years

  • Cytogenetics requirements:

    • Southwestern Oncology Group (SWOG) (and other sites not affiliated with Alliance or Eastern Cooperative Oncology Group [ECOG]-American College of Radiology Imaging Network [ACRIN]): Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred Clinical Laboratory Improvement Amendments (CLIA)-approved cytogenetics laboratory; reports of the results must be submitted as described; note that cytogenetics are required at other timepoints; NOTE: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) sites may submit specimens to College of American Pathologists (CAP) or Ontario Laboratory Accreditation (OLA)-approved laboratories providing the lab is licensed to perform fluorescent in situ hybridization (FISH) analysis
    • Alliance: Alliance patients must enroll on Cancer and Leukemia Group B (CALGB) 8461, the cytogenetics protocol; CALGB 8461 provides sample procurement and submission instructions to Alliance-approved institutional cytogeneticists; note that cytogenetics are required at other timepoints
    • ECOG-ACRIN: Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred CLIA-approved cytogenetics laboratory; karyotypes and reports must be submitted for review to the Mayo Clinic Cytogenetics Laboratory in Rochester; note that cytogenetics testing is required at other timepoints
  • Banking requirements:

    • SWOG, Alliance and ECOG-ACRIN (and other sites not affiliated with NCIC CTG): Patients must be offered participation in specimen banking; with patient consent, specimens must be submitted as outlined
    • Alliance: (Temporarily Closed 2/28/14): As of February 28, 2014, CALGB 9665 has been temporarily closed, so Alliance patients under consideration for S1117 are NOT to be registered to CALGB 9665 and no specimens for patients enrolled after February 28, 2014 are to be submitted via this ancillary study; these patients should submit specimens per SWOG instructions; patients already enrolled on CALGB 9665 should continue to submit specimens per instructions in CALGB 9665
    • NCIC CTG: NCIC CTG patients must be offered participation in specimen submission and banking; with patient consent, specimens must be submitted as outlined
  • All patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

  • As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Arm I (azacitidine and lenalidomide)

Patients receive azacitidine SC or IV on days 1-7 or days 1-5 and 8-9, and lenalidomide PO QD on days 1-21. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given PO

Andere namen:
  • CC-5013
  • Revlimid
  • CC5013
  • CDC 501
  • CC 5013

Given SC or IV

Andere namen:
  • 5 AZC
  • 5-AC
  • 5-Azacytidine
  • 5-AZC
  • Azacytidine
  • Azacytidine, 5-
  • Ladakamycine
  • Mylosar
  • U-18496
  • Vidaza
  • 5-Azacitidine
Experimenteel: Arm II (azacitidine)

Patients receive azacitidine as in Arm I. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given SC or IV

Andere namen:
  • 5 AZC
  • 5-AC
  • 5-Azacytidine
  • 5-AZC
  • Azacytidine
  • Azacytidine, 5-
  • Ladakamycine
  • Mylosar
  • U-18496
  • Vidaza
  • 5-Azacitidine
Experimenteel: Arm III (azacitidine and vorinostat)

Patients receive azacitidine as in Arm I and vorinostat PO BID on days 3-9. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.

Correlative studies

Given SC or IV

Andere namen:
  • 5 AZC
  • 5-AC
  • 5-Azacytidine
  • 5-AZC
  • Azacytidine
  • Azacytidine, 5-
  • Ladakamycine
  • Mylosar
  • U-18496
  • Vidaza
  • 5-Azacitidine

Given PO

Andere namen:
  • SAHA
  • Suberoylanilide Hydroxaminezuur
  • MSK-390
  • Zolinza
  • L-001079038
  • Suberanilohydroxamzuur

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Response Rate (Phase II)
Tijdsspanne: Up to 5 years

A response is any of complete hematological remission, partial remission, or hematologic improvement.

Up to 5 years
Overall Survival (Phase III)
Tijdsspanne: Up to 5 years

OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow-up for patients last known to be alive is censored at the date of last contact. Stratified Cox regression models will be used to compare OS of the combination arm selected in the Phase II portion of the trial to OS of the single-agent azacitidine arm.

Up to 5 years

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Relapse-free Survival
Tijdsspanne: Up to 5 years

RFS is calculated for patients who have achieved a response. RFS will be measured from the date of response to the date of first documentation of relapse from response (as defined in the primary objective), or death due to any cause. The follow-up for patients last known to be alive and without report of relapse is censored at the date of last contact. RFS will be estimated for each of the three arms using the Kaplan-Meier method.

Up to 5 years
Overall Survival
Tijdsspanne: Up to 5 years

OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow- up for patients last known to be alive is censored at the date of last contact. OS will be estimated for each of the three arms using the Kaplan-Meier method.

Up to 5 years
Pre-study Cytogenetic Abnormalities
Tijdsspanne: Up to 5 years

Cytogenetic risk group is used to identify cytogenetic abnormalities.

Up to 5 years
Toxicity Rate
Tijdsspanne: Up to 5 years

Adverse events that are possibly, probably or definitely related to study drug are reported.

Up to 5 years

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Mikkael A Sekeres, SWOG Cancer Research Network

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 maart 2012

Primaire voltooiing (Werkelijk)

1 juni 2015

Studie voltooiing (Geschat)

31 maart 2027

Studieregistratiedata

Eerst ingediend

27 januari 2012

Eerst ingediend dat voldeed aan de QC-criteria

27 januari 2012

Eerst geplaatst (Geschat)

1 februari 2012

Updates van studierecords

Laatste update geplaatst (Werkelijk)

18 november 2026

Laatste update ingediend die voldeed aan QC-criteria

17 november 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren